| JPM THEMATICS-GENETIC THERAPIES A (DIST) EUR (HEDGED) | BIOTECNOLOGÍA | 26,95% | -0,68% | -42,27% | · |
| XTRACKERS MSCI EMERGING MARKETS UCITS ETF 1C | RVI EMERGENTES | 26,95% | 43,20% | 27,64% | · |
| AB SICAV I-EUROPEAN EQUITY PORTFOLIO A USD | RVI EUROPA | 26,94% | 37,86% | 56,49% | 104,40% |
| AMUNDI MSCI EM ASIA UCITS ETF EUR CAP | RVI ASIA | 26,94% | 44,22% | 22,80% | · |
| GOLDMAN SACHS ALL CHINA EQUITY PORTFOLIO BASE USD CAP | RVI CHINA | 26,94% | 5,68% | -27,07% | 78,13% |
| JPM EUROLAND EQUITY I2 (ACC) EUR | RV EURO | 26,94% | 62,00% | 94,55% | · |
| NORDEA 1-STABLE EMERGING MARKETS EQUITY FUND BC-EUR | RVI EMERGENTES | 26,94% | 34,94% | 53,14% | · |
| PRIVILEDGE - JPMORGAN EUROZONE EQUITY (GBP) P CAP SYST. HDG | RV EURO | 26,94% | 70,12% | 103,00% | · |
| DWS INVEST ESG EMERGING MARKETS TOP DIVIDEND PFC | RVI EMERGENTES | 26,93% | 41,38% | 21,54% | 79,98% |
| ISHARES EMERGING MARKETS EQUITY INDEX FUND (LU) X2 USD CAP | RVI EMERGENTES | 26,93% | 43,81% | 27,95% | · |
